Hexaminolevulinate: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Hexaminolevulinate. Educational only — not medical advice.
Labeled uses
CYSVIEW is indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients: With suspected or known lesion(s) based on a prior cystoscopy Undergoing surveillance cystoscopy for bladder cancer Limitations of Use CYSVIEW is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [see Warnings and Precautions (5.2) ] .
Source: FDA labeling via NIH DailyMed (set 5aeed40d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.